Injective (INJ) is currently trading at $3.27, reflecting a 24-hour change of 3.56%. The daily trading range has been narrow, with a high of $3.29 and a low of $3.12, indicating relatively stable market conditions within this timeframe.

The trading volume of approximately $62.6 million accounts for 19.08% of the market capitalization, suggesting a healthy liquidity environment for INJ. The short-term moving averages (8, 13, 21 SMA) indicate positive momentum, with each showing gains of over 3%, while the 55 SMA is neutral and the 144 SMA indicates a bearish trend over a longer period.

Currently, the 1-hour RSI is at 68, approaching overbought territory, while the 7-day RSI sits at 50, suggesting a balanced market sentiment in the medium term. The price changes over the last 7 and 14 days are positive at 5.59% and 9.62%, respectively, but the 30-day change shows a significant decline of -25.32%, indicating a longer-term bearish sentiment.

Injective's all-time high stands at $52.62, reached in March 2024, which highlights the substantial potential upside compared to the current price. However, the recent price performance indicates volatility and the need for caution, especially with the 30-day trend reflecting a significant downturn.

Based on the current analysis, the recommendation for Injective (INJ) is to Hold. The positive short-term momentum is encouraging, but the long-term bearish trend and approaching overbought levels on the RSI suggest that investors should wait for clearer bullish signals or a pullback before increasing exposure.